Breaking Down Haohua Chemical Science & Technology Corp., Ltd. Financial Health: Key Insights for Investors

Haohua Chemical's recent numbers demand attention: in Q3 ended Sept 30, 2025 revenue hit CNY 4.54 billion (up 22.33% YoY) and TTM revenue reached CNY 16.06 billion (up 21.82% YoY), while market capitalization sits near CNY 39.47 billion (Dec 16, 2025); profitability shows momentum too - H1 2025 net profit was CNY 640 million (a 20.85% YoY increase) with projected H1 net profit of CNY 590-650 million (up 59.30%-75.50%), TTM EPS is CNY 1.15 with a P/E around 26.52 and trailing P/E/forward P/E at 28.39/17.44, and balance-sheet metrics reveal a net cash position of CNY 1.36 billion (total debt CNY 3.55 billion, cash CNY 4.91 billion), solid liquidity (current ratio 1.5, quick ratio 1.2, cash ratio 0.5) and a free cash flow margin of 10%; read on to unpack valuation (P/S ~2.4, P/B 1.99, EV/EBITDA 18.45), leverage, risks from raw material and regulatory exposure, and the growth levers in fluorochemicals, international expansion, R&D and sustainability that could reshape investor outcomes.

Haohua Chemical Science & Technology Corp., Ltd. (600378.SS) Revenue Analysis

Haohua Chemical Science & Technology Corp., Ltd. reported strong top-line momentum through September 30, 2025, with notable quarterly and trailing figures that contrast with the prior-year annual decline.

• Quarter ending Sep 30, 2025 revenue: CNY 4.54 billion (up 22.33% YoY).
• TTM revenue as of Sep 30, 2025: CNY 16.06 billion (up 21.82% YoY).
• Full-year 2024 revenue: CNY 13.97 billion (down 3.83% vs. 2023).

• Revenue rebound in 2025 is pronounced: TTM and quarterly growth >21% after a modest annual decline in 2024.
• Revenue per employee (CNY 1.37M) and a workforce of 11,708 indicate scale and operational productivity metrics investors may benchmark against peers.
• P/S of 2.46 combined with CNY 39.47 billion market cap suggests the market is pricing future revenue expansion into current valuation.

For broader investor context and shareholder activity, see: Exploring Haohua Chemical Science & Technology Corp., Ltd. Investor Profile: Who's Buying and Why?

Haohua Chemical Science & Technology Corp., Ltd. (600378.SS) - Profitability Metrics

Key profitability indicators for Haohua Chemical Science & Technology Corp., Ltd. (600378.SS) show solid operating performance and a moderate market valuation through the trailing twelve months (TTM) and the first half of 2025.

• Revenue and margin drivers: stable product demand in chemical intermediates, improved production efficiencies, and disciplined cost control contributing to the 8.9% net margin and 7.58% operating margin.
• Profit growth: H1 2025 net profit reached CNY 640 million (YoY +20.85%), while management projected a range implying up to +75.50% YoY under certain accounting/period comparisons.
• Capital efficiency: ROE at 8.5% signals reasonable returns but suggests room for improvement versus higher-growth peers.
• Valuation context: EPS of CNY 1.15 and P/E 26.52 indicate the market prices recent earnings at a moderate premium.

• Investor considerations: compare operating margin (7.58%) and net margin (8.9%) with sector peers to assess competitive positioning.
• Volatility factors: commodity price swings and feedstock costs may compress margins; monitor raw material trends and hedging policies.
• Profitability outlook: sustained margin improvements and controlled SG&A will be key to converting projected net profit ranges into realized earnings.

Further company context and shareholder dynamics can be reviewed here: Exploring Haohua Chemical Science & Technology Corp., Ltd. Investor Profile: Who's Buying and Why?

Haohua Chemical Science & Technology Corp., Ltd. (600378.SS) - Debt vs. Equity Structure

• Total debt (Mar 2025): CNY 3.55 billion (up from CNY 2.77 billion year-over-year).
• Cash and cash equivalents: CNY 4.91 billion - yielding a net cash position of CNY 1.36 billion.
• Debt-to-equity ratio: ~0.1, implying equity of approximately CNY 35.5 billion (Debt / Equity ≈ 0.1).
• Current ratio: 1.5 - adequate short-term coverage of liabilities.
• Quick ratio: 1.2 - sufficient immediate liquidity excluding inventories.
• Interest coverage ratio: 5 - EBIT covers interest expense five times, indicating comfortable serviceability.

• Implication for investors: net cash and low D/E reduce solvency risk and provide flexibility for capex, M&A, or shareholder returns.
• Possible trade-offs: rising nominal debt YoY warrants monitoring if growth capex or working-capital needs accelerate.
• Liquidity profile (current and quick ratios) supports operations through typical cyclical swings in the chemical sector.

Haohua Chemical Science & Technology Corp., Ltd. (600378.SS) - Liquidity and Solvency

• Current ratio: 1.5 - short-term assets are 1.5× short-term liabilities, signaling adequate coverage of upcoming obligations.
• Quick ratio: 1.2 - sufficient liquid assets (ex‑inventory) to cover immediate liabilities.
• Cash ratio: 0.5 - cash and cash equivalents equal 50% of current liabilities, a moderate cash buffer.
• Operating cash flow ratio: 1.8 - operating cash flows are 1.8× current liabilities, reflecting strong cash generation from core operations.
• Free cash flow margin: 10% - 10% of revenue converts to free cash flow after capital expenditures, supporting reinvestment, dividends, or debt reduction.
• Solvency ratio: 0.2 - liabilities are 20% of total assets (or equity/assets relationship yielding a 0.2 solvency measure), indicating low financial leverage and greater long‑term solvency.

• With an operating cash flow ratio of 1.8 and a 10% free cash flow margin, the company demonstrates the ability to fund operations and reinvest without excessive reliance on external financing.
• The combination of a 1.5 current ratio and 1.2 quick ratio reduces short‑term liquidity risk, even in periods of slower revenue realization.
• A cash ratio of 0.5 suggests management maintains a balance between holding cash and deploying capital into growth or working capital needs.
• The 0.2 solvency ratio highlights a low leverage position, which can provide strategic flexibility for acquisitions, dividend policy, or debt service resilience during downturns.

Haohua Chemical Science & Technology Corp., Ltd. (600378.SS) - Valuation Analysis

Key valuation metrics for Haohua Chemical Science & Technology Corp., Ltd. (600378.SS) provide a snapshot of how the market prices the company today versus its revenues, book value and earnings power.

• Trailing P/E: 28.39 - current price implies a premium on last 12 months' earnings.
• Forward P/E: 17.44 - market expects material earnings growth over the next 12 months.
• Price-to-Sales (P/S): 2.41 - investors pay CNY 2.41 for every CNY 1 of revenue.
• Price-to-Book (P/B): 1.99 - shares trade at nearly 2x book value.
• EV/Revenue: 2.39 - enterprise value roughly 2.39 times annual revenue.
• EV/EBITDA: 18.45 - valuation relative to operating cash earnings indicates modest leverage.
• Market Capitalization (as of 2025-12-04): CNY 38.43 billion.

Contextual considerations and next-step metrics investors typically cross-check include growth assumptions embedded in the forward P/E, margin trends that justify the EV/EBITDA multiple, and comparisons to chemical-sector peers on P/S and P/B.

• Compare forward earnings estimates to recent guidance and analyst consensus.
• Benchmark P/S, P/B and EV/EBITDA against domestic and international chemical manufacturers.
• Monitor capital expenditure plans and working capital trends that affect enterprise value drivers.

For further company background and investor composition, see: Exploring Haohua Chemical Science & Technology Corp., Ltd. Investor Profile: Who's Buying and Why?

Haohua Chemical Science & Technology Corp., Ltd. (600378.SS) Risk Factors

Haohua Chemical operates in specialty electronic chemicals and broader chemical manufacturing. The company's financial resilience depends on cost control, customer diversification, regulatory compliance, and stable plant operations. Below are the principal risks with associated quantitative indicators to help investors assess potential impact.

• Intense market competition in electronic chemicals - margin pressure and potential market share erosion.
• Volatility in raw material prices - direct impact on COGS and gross margin sensitivity.
• Environmental and regulatory policy shifts - potential for increased compliance capital and operating expenditure.
• Currency exchange rate fluctuations - affects export revenue and overseas procurement costs.
• Operational risks from large-scale manufacturing - downtime, safety incidents, and capacity-utilization swings.
• Dependence on key customers and suppliers - concentration risk to revenue and procurement stability.

Risk drivers and potential financial impacts to monitor:

• Raw material spikes: a 10% rise in key feedstock prices could reduce gross margin by ~2-3 percentage points if not fully passed to customers.
• Customer concentration: loss of a top customer (representing ~10-15% revenue) could reduce annual revenue materially and force excess capacity.
• Environmental compliance: one-time retrofit capex for stricter standards could exceed several hundred million CNY depending on plant and technology choices.
• Operational downtime: a prolonged shutdown at a major site could cut quarterly output by 20-35% for affected product lines.
• FX movements: a 5% weakening of CNY versus USD could reduce dollar-denominated margins on exports and increase costs of imported intermediates.

Mitigating indicators to watch in financial statements and disclosures:

• Trend in gross margin and inventory days - signals raw-material pass-through and stock build-up.
• Receivables aging and concentration - assesses customer credit and revenue stability.
• CapEx and environmental provision disclosures - indicate regulatory and modernization commitments.
• Debt maturity profile and interest coverage - measure resilience to cash-flow shocks.
• R&D and product-mix shifts toward higher-margin electronic-chemical specialties - potential margin defense.

For the company's stated direction and corporate principles that frame strategic risk responses, see: Mission Statement, Vision, & Core Values (2026) of Haohua Chemical Science & Technology Corp., Ltd.

Haohua Chemical Science & Technology Corp., Ltd. (600378.SS) - Growth Opportunities

• Refrigerant market expansion: Global demand recovery and phase-down of high-GWP refrigerants support higher volumes and premium pricing for low-GWP alternatives (industry refrigerant market CAGR ~4-6% through 2028).
• Export diversification: Increasing shipments to Southeast Asia, Europe and select emerging markets can reduce reliance on domestic demand and smooth cyclical volatility.
• R&D-driven product pipeline: New refrigerant blends, fluorinated intermediates and specialty fluoropolymers can command higher margins and create stickier customer relationships.
• M&A and capacity consolidation: Targeted acquisitions of niche fluorochemical producers or downstream formulators can boost market share and realize synergies.
• Sustainability premium: Transitioning production to low-emission processes and green feedstocks can unlock ESG-conscious buyers and potential pricing premiums.
• Digitalization & automation: Factory automation and advanced process controls offer measurable reductions in unit costs, yield improvements and safety gains.

• Accelerate commercialization of low-GWP refrigerants and specialty fluorochemicals developed in-house to command premium margins.
• Allocate capex to retrofit production lines for lower-emission processes and to add automation that reduces per-unit labor and energy costs.
• Pursue bolt-on acquisitions in downstream formulations and regional distributors to shortcut market entry and scale international sales.
• Build partnerships with OEMs and distributors in target export markets to secure long-term offtake and accelerate product adoption.
• Increase disclosure on ESG metrics and lifecycle emissions to attract institutional investors focused on sustainability.